Insider filing · REGN
Christine A Poon
Director
profile →
Regeneron Pharmaceuticals, Inc.
REGN · Healthcare · 35 filings in 24 months
ticker →
Christine A Poon sold $4.2M of Regeneron Pharmaceuticals (REGN)
Executed Oct 29 2025, disclosed Oct 31 2025, 2 days later.
Value, as filed
$4.2M
6,400 sh across 5 lots
Executed
Oct 29 2025
the trade date, as filed
Disclosed
Oct 31 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
CPChristine A Poon (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Regeneron Pharmaceuticals, Inc. (REGN). The largest single filing was $7.6M of REGN (7,830 sh across 6 lots, as filed), executed Nov 2.
The name
REGNHealthcare · Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Christine A Poon in REGN
REGNSALE
Regeneron Pharmaceuticals, Inc.
$7.6M7,830 sh across 6 lots
Exec Nov 2
Filed Nov 4 · 4:09 PM ET